Pustular skin diseases refl ect distinct innate defense pathways

References

• Iwatsuki K, Yamasaki O, Morizane S, Oono T. Staphylococcal cutaneous infections: invasion, evasion and aggression. J. Dermatol. Sci.42, 203–214 (2006).
   PubMed Web of Science ®Google Scholar
• Fox AB, Hambrick GW Jr. Recreationally associated Pseudomonas aeroginosa folliculitis. Arch. Dermatol.120, 1304–1307 (1984).
   PubMedGoogle Scholar
• Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanism, and associated risks. Clin. Microbiol. Rev.10, 505–520 (1997).
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Janeway CA. Innate immunity. N. Engl. J. Med.343, 338–344 (2000).
   PubMed Web of Science ®Google Scholar
• Foster TJ. Immune evasion by staphylococci. Nat. Rev. Microbiol.3, 948–958 (2005).
   PubMed Web of Science ®Google Scholar
• Mertz PM, Cardenas TCP, Snyder RV, Kinney MA, Davis SC, Plano LRW. Staphylococcus aureus virulence factors associated with infected skin lesions. Arch. Dermatol.143, 1259–1263 (2007).
   PubMedGoogle Scholar
• Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin. Microbiol. Rev.18, 521–540 (2005).
   PubMed Web of Science ®Google Scholar
• Hornung V, Rothenfusser S, Britsch S et al. Quantitative expression of Toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol.168, 4531–4537 (2002).
   PubMed Web of Science ®Google Scholar
• Peiser L, Mukhopadhyay S, Gordon S. Scavenger receptors in innate immunity. Curr. Opin. Immunol.14, 123–128 (2002).
   PubMed Web of Science ®Google Scholar
• Carneiro LAM, Magalhaes JG, Tattoli I, Philpott DJ, Travassos LH. Nod-like proteins in inflammation and disease. J. Pathol.214, 136–148 (2008).
   PubMed Web of Science ®Google Scholar
• Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature442, 39–44 (2006).
   PubMed Web of Science ®Google Scholar
• Bottazzi B, Garlanda C, Salvatori G, Jeannin P, Manfredi A, Mantovani A. Pentraxins as a key component of innate immunity. Curr. Opin. Immunol.18, 10–15 (2006).
   PubMed Web of Science ®Google Scholar
• Eisen DP, Liley HG, Minchinton RM. Alternatives to conventional vaccines – mediators of innate immunity. Curr. Drug Targets5, 89–105 (2004).
   PubMedGoogle Scholar
• Imler JL, Hoffmann JA. Toll-like receptors in Drosophila: a family of molecules regulating development and immunity. Curr. Top. Microbiol. Immunol.270, 63–80 (2002).
   PubMed Web of Science ®Google Scholar
• O’Neill JA. Signal transduction pathwaysactivated by the IL-1 receptor/Toll-like receptor superfamily. Curr. Top. Microbiol. Immunol.270, 47–62 (2002).
   PubMed Web of Science ®Google Scholar
• Underhill DM. Toll-like receptors: networking for success. Eur. J. Immunol.33, 1767–1775 (2003).
   PubMed Web of Science ®Google Scholar
• Hemmrich G, Miller DJ, Bosch TCG. The evolution of immunity: a low-life perspective. Trends Immunol.28, 449–454 (2007).
   PubMedGoogle Scholar
• Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol.14, 103–110 (2002).
   PubMed Web of Science ®Google Scholar
• Travassos LH, Giardin SE, Philpott DJ et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Reports5, 1000–1006 (2004).
   PubMed Web of Science ®Google Scholar
• Schröder JM, Harder J. Antimicrobial peptides and proteins. Cell. Mol. Life Sci.63, 469–486 (2006).
   PubMed Web of Science ®Google Scholar
• Graham GM, Farrar MD, Cruse-Sawyer JE et al. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br. J. Dermatol.150, 421–428 (2004).
   PubMed Web of Science ®Google Scholar
• Schaller M, Loewenstein M, Borelli C et al. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterum acnes and coproporphyrin III. Br. J. Dermatol.153, 66–71 (2005).
   PubMed Web of Science ®Google Scholar
• Mempel M, Voelcker V, Köllisch G et al. Toll-like receptor expression in human keratinocytes: nuclear factor κB controlled gene activation by Staphylococcus aureus is Toll-like receptor 2 but not Toll-like receptor 4 or platelet activating factor receptor dependent. J. Invest. Dermatol.121, 1389–1396 (2003).
   PubMedGoogle Scholar
• Sasaki T, Kano R, Sato H, Nakamura Y, Watanabe S, Hasegawa A. Effects of staphylococci on cytokine production from human keratinocytes. Br. J. Dermatol.148, 46–50 (2003).
   PubMed Web of Science ®Google Scholar
• Schröder JM, Gregory H, Young J, Christophers E. Neutrophil-activating proteins in psoriasis. J. Invest. Dermatol.98, 241–247 (1992).
   PubMedGoogle Scholar
• Schröder JM, Christophers E. The biology of NAP-1/IL-8, a neutrophil activating cytokine. Immunol. Ser.57, 387–416 (1992).
   PubMedGoogle Scholar
• Schröder JM, Christophers E. Identification of C5a des arg and anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J. Invest. Dermatol.87, 53–58 (1986).
   PubMed Web of Science ®Google Scholar
• Fritz JH, Le Bourhis L, Magalhaes JG, Philpott DJ. Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat. Trends Immunol.29, 41–49 (2008).
   PubMed Web of Science ®Google Scholar
• Fritz JH, Le Bourhis L, Sellge E et al. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity26, 445–459 (2007).
   PubMed Web of Science ®Google Scholar
• Gamero AM, Oppenheim JJ. IL-1 can act as number one. Immunity24, 16–17 (2006).
   PubMed Web of Science ®Google Scholar
• Miller LS, Pietras EM, Uricchio LH et al. Inflammasome-mediated production of IL-1β is required for neutrophil recruitment against Staphylococcus aureusin vivo. J. Immunol.179, 6933–6942 (2007).
   PubMed Web of Science ®Google Scholar
• Matsukawa A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M. Analysis of the cytokine network among tumor necrosis factor α, interleukin-1 β, interleukin-8, and interleukin-1 receptor antagonist in monosodium orate crystal-induced rabbit arthritis. Lab. Invest.78, 559–569 (1998).
   PubMed Web of Science ®Google Scholar
• Matsukawa A, Yoshimura T, Fujiwara K, Maeda T, Ohkawara S, Yoshinaga M. Involvement of growth-related protein in lipopolysaccharide-induced rabbit arthritis: cooperation between growth-related protein and IL8, and interrelated regulation among TNF-α, IL-1, IL-1 receptor antagonist, IL-8, and growth-related protein. Lab. Invest.79, 591–600 (1999).
   PubMed Web of Science ®Google Scholar
• Miller LS, O’Connell RM, Gutierrez MA et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity24, 79–91 (2006).
   PubMed Web of Science ®Google Scholar
• Zaba LC, Fuentes-Duculan J, Steinman RM, Krueger JG, Lowes MA. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J. Clin. Invest.117, 2517–2525 (2007).
   PubMed Web of Science ®Google Scholar
• Nickoloff BJ, Karabin GD, Barker JN et al. Cellular localization of interleukin 8 and its inducer, tumor necrosis factor-α in psoriasis. Am. J. Pathol.138, 129–140 (1991).
   PubMed Web of Science ®Google Scholar
• Sayers TJ, Wiltrout TA, Bull CA, Denn AC 3rd, Pilaro AM, Lokesh B. Effects of cytokines on polymorphonuclear neutrophil infiltration in the mouse: prostaglandine- and leukotriene-independent induction of infiltration by IL-1 and tumor necrosis factor. J. Immunol.141, 1670–1678 (1988).
   PubMedGoogle Scholar
• Menegazzzi R, Cramer R, Patriarca P, Scheurich P, Dri P. Evidence that tumor necrosis factor α (TNF)-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor. Blood84, 287–293 (1994).
   PubMedGoogle Scholar
• Miskolci V, Rollins J, Vu HY, Ghosh CC, Davidson D, Vancurova I. NFκB is persistently activated in continuously stimulated human neutrophils. Mol. Med.13, 134–142 (2007).
   PubMed Web of Science ®Google Scholar
• Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. J. Allergy Clin. Immunol.120, 247–254 (2007).
   PubMed Web of Science ®Google Scholar
• Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol.8, 950–957 (2007).
   PubMed Web of Science ®Google Scholar
• Dragon S, Rahman MS, Yang J, Unruh H, Halayko AJ, Gounni AS. IL-17 enhances IL-1β-mediated CXCL-8 release from human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol.292, 1023–1029 (2007).
   PubMed Web of Science ®Google Scholar
• Kolls JK, Linden A. Interleukin 17 family members and inflammation. Immunity21, 467–476 (2004).
   PubMed Web of Science ®Google Scholar
• Ye P, Rodriguez FH, Kanaly S et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med.194, 519–527 (2001).
   PubMed Web of Science ®Google Scholar
• Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis.190, 624–631 (2004).
   PubMed Web of Science ®Google Scholar
• Christophers E. Comorbidities in psoriasis. Clin. Dermatol.25, 529–534 (2007).
   PubMed Web of Science ®Google Scholar
• Baker H, Ryan TJ. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br. J. Dermatol.80, 771–793 (1968).
   PubMedGoogle Scholar
• Rocha-Pereira P, Santos-Silva A, Rebelo I et al. The inflammatory response in mild and severe psoriasis. Br. J. Dermatol.150, 917–928 (2004).
   PubMed Web of Science ®Google Scholar
• Sergeant A, Makrygeorgou A, Chan WC, Thorrat A, Burden D. C-reactive protein in psoriasis. Br. J. Dermatol.158, 417–419 (2008).
   PubMed Web of Science ®Google Scholar
• Beg AA. Endgenous ligands of Toll-like receptors: implications for regulating inflammatroy and immune responses. Trends Immunol.23, 509–512 (2002).
   PubMed Web of Science ®Google Scholar
• Biragyn A, Ruffini PA, Leifer CA et al. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science298, 1025–1029 (2002).
   PubMed Web of Science ®Google Scholar
• Lau CM, Broughton C, Tabor AS et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med.202, 1171–1177 (2005).
   PubMed Web of Science ®Google Scholar
• Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature449, 564–569 (2007).
   PubMed Web of Science ®Google Scholar
• Korn T, Oukka M, Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin. Immunol.19(6), 362–371 (2007).
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Kuchroo VK. Th17: The third member of the effector T cell trilogy. Curr. Opin. Immunol.19, 652–657 (2007).
   PubMed Web of Science ®Google Scholar
• Hemmi H, Kaisho O, Takeuchi S et al. Small anti-viral compounds acitivate immune cells via the TLR7 MyD88-dependent signalling pathway. Nat. Immunol.3, 196–200 (2002).
   PubMed Web of Science ®Google Scholar
• Jurk M, Heil F, Vollmer J et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R848. Nat. Immunol.3, 499 (2002).
   PubMed Web of Science ®Google Scholar
• Gilliet M, Conrad C, Geiges M et al. Psoriasis triggered by Toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch. Dermatol.140, 1490–1495 (2004).
   PubMed Web of Science ®Google Scholar
• Rajan N, Langtry JA. Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clin. Exp. Dermatol.31, 140–141 (2006).
   PubMed Web of Science ®Google Scholar
• Fanti PA, Dika E, Vaccari S, Miscial C, Varotti C. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int. J. Dermatol.45, 1464–1465 (2006).
   PubMed Web of Science ®Google Scholar
• Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD. Human lupus autoantibody DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest.115, 407–417 (2005).
   PubMed Web of Science ®Google Scholar
• Claudy A. Pathogenesis of leukocytoclastic vasculitis. Eur. J. Dermatol.8, 75–79 (1998).
   PubMedGoogle Scholar
• Nestle FO, Conrad C, Tun-Kyi A et al. Plasmacytoid predendritic cells (PDC) initiate psoriasis through IFN-a production. J. Exp. Med.202, 135–143 (2005).
   PubMed Web of Science ®Google Scholar
• McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23–IL17 immune pathway. Trends Immunol.27, 17–23 (2006).
   PubMed Web of Science ®Google Scholar
• Langowski JL, Kastelein RA, Oft M. Swords into plowshares: IL-23 repurposes tumor immune surveillance. Trends Immunol.28, 207–211 (2007)
   PubMed Web of Science ®Google Scholar
• Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest.116, 1218–1222 (2006).
   PubMed Web of Science ®Google Scholar
• Smits HH, van Beelen AJ, Hessle C et al. Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur. J. Immunol.34, 1371–1380 (2004).
   PubMed Web of Science ®Google Scholar
• Dong C. Diversification of T-helper cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol.6, 329–333 (2006).
   PubMed Web of Science ®Google Scholar
• Sa S, Valdez PA, Wu J et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol.78, 2229–2240 (2007).
   Google Scholar
• Linden A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur. Respir. J.25, 159–172 (2005).
   PubMed Web of Science ®Google Scholar
• Yao Z, Paintner SL, Fanslow WC et al. Human IL-17: a novel cytokine derived from T cells. J. Immunol.155, 5483–5486 (1995).
   PubMed Web of Science ®Google Scholar
• Shen F, Hu Z, Goswami J, Gaffen SL. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J. Biol. Chem.281, 24138–24148 (2006).
   PubMed Web of Science ®Google Scholar
• Patel DN, King CA, Bailey SR et al. Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NFκB and C/EBPβ activation. J. Biol. Chem.282, 27229–27238 (2007).
   PubMed Web of Science ®Google Scholar
• Takematsu H, Tagami H. Quantification of chemotactic peptides (C5a anaphylatoxin and IL8) in psoriatic lesional skin. Arch. Dermatol.129, 74–80 (1993).
   PubMedGoogle Scholar
• Katz Y, Nadiv O, Rapoport MJ, Loos M. IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts. Clin. Exp. Immunol.120, 22–29 (2000).
   PubMedGoogle Scholar
• Van de Kerkhof PC. Update on retinoid Therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol. Ther.19, 252–263 (2006).
   PubMed Web of Science ®Google Scholar
• Christophers E, Griffith CE, Gaitanis G, van de Kerkhoff P. The unmet treatment need for moderate to severe psoriasis: results of a survey and chart view. J. Eur. Acad. Dermatol. Venereol.20, 921–925 (2006).
   PubMed Web of Science ®Google Scholar
• Mucida D, Park Y, Turovskaya O, Scott I, Kronenberg M, Choutre H. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science317, 256–260 (2007).
   PubMed Web of Science ®Google Scholar
• Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology209, 123–129 (2005).
   PubMed Web of Science ®Google Scholar
• Sidoroff A, Dunant A, Vibout C et al. Risk factors for acute generalized exanthematous pustulosis (AGEP) – results of a multinational case-control study (EuroSCAR). Br. J. Dermatol.157, 989–996 (2007).
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Recognition of viruses by innate immunity. Immunol. Rev.220, 214–224 (2007)
   PubMed Web of Science ®Google Scholar
• Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol.25, 381–386 (2004).
   PubMed Web of Science ®Google Scholar
• Johnson GB, Brunn GJ, Tang AH, Platt JL. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol.24, 19–24 (2003).
   PubMed Web of Science ®Google Scholar
• Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin–IgG-complexes activate B cells by dual engagement of IgM and Toll-like receptor. Nature416, 603–607 (2002).
   PubMed Web of Science ®Google Scholar
• Lebre MC, van der Aar AMG, van Baarsen L et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol.127, 331–341 (2007).
   PubMed Web of Science ®Google Scholar
• Köllisch G, Kalali BN, Voelcker V et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology114, 531–541 (2005).
   PubMed Web of Science ®Google Scholar
• Nagase H, Okugawa S, Ota Y et al. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol.171, 3977–3982 (2003).
   PubMed Web of Science ®Google Scholar
• Hasan U, Chaffois C, Gaillard C et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J. Immunol.174, 2942–2950 (2005).
   PubMed Web of Science ®Google Scholar
• Gorden KB, Gorski KS, Gibson SJ et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J. Immunol.174, 1259–1268 (2005).
   PubMed Web of Science ®Google Scholar
• O’Neill L. How Toll-like receptors signal: what we know and what we don’t know. Curr. Opin. Immunol.18, 3–9 (2006).
   PubMed Web of Science ®Google Scholar
• Jarrossay D, Napolitani G, Colonna M, Salusto F, Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol.31, 3388–3893 (2001)
   PubMed Web of Science ®Google Scholar
• Ito T, Amakawa R, Kaisho T et al. Interferon-α and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med.195, 1507–1112 (2002).
   PubMed Web of Science ®Google Scholar
• Krug A, Towarowski A, Britsch S et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with Cd40 ligand to induce high amounts of IL-12. Eur. J. Immunol.31, 3026–3037 (2001).
   PubMed Web of Science ®Google Scholar
• Kadowaki N, Ho S, Antonenko R et al. Subsetes of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med.194, 863–869 (2001).
   PubMed Web of Science ®Google Scholar
• Martinon F, Tschopp J. NLR join TLRs as innate sensors of pathogens. Trends Immunol.26, 447–454 (2005).
   PubMed Web of Science ®Google Scholar
• Uehara A, Fulimoto Y, Fukase K, Takada H. Various human epithelila cells express functional Toll-like receptors, NOD1 and NOD2, to produce antimicrobial peptides, but not proinflammatory cytokines. Mol. Immunol.44, 3100–3111 (2007).
   PubMed Web of Science ®Google Scholar
• Gutierrez O, Pipaon C, Inohara N et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor κB activation. J. Biol. Chem.277, 41701–41705 (2002).
   PubMed Web of Science ®Google Scholar
• Beiter K, Wartha F, Albiger B et al. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr. Biol.16, 401–407 (2006).
   PubMed Web of Science ®Google Scholar
• Fritz JH, Giardin SE, Fitting C et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur. J. Immunol.35, 2459–2470 (2005).
   PubMed Web of Science ®Google Scholar
• Tada H, Aiba S, Shibata K, Ohteki T, Takada H. Synergistic effect of Nod1 and Nod2 agonists with Toll-like receptor agonists on human dendritic cells to genereate interleukin-12 and T helper type 1 cells. Infect. Immun.73, 7067–7976 (2005).
   Google Scholar
• Anders HJ. Innate pathogen recognition in the kidney: Toll-like receptors, NOD-like receptors, and RIG-like helicases. Kidney Int.72, 1051–1056 (2007).
   PubMed Web of Science ®Google Scholar
• Kato H, Sato S, Yoneyama M et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity23, 19–28 (2005).
   PubMed Web of Science ®Google Scholar